Nephro Care India Limited (NSE:NEPHROCARE)
India · Delayed Price · Currency is INR 91.45
+4.20 (4.81%)
At close: Sep 10, 2026
Nephro Care India Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 33.69 | 36.39 | 44.11 | 23.73 | -0.1 |
Depreciation & Amortization | 50.74 | 24.6 | 5.28 | 7.84 | 1.11 |
Loss (Gain) From Sale of Investments | -4.45 | -10.8 | -2.61 | - | - |
Other Operating Activities | -4.13 | -1.38 | -4.91 | 1.69 | -0.45 |
Change in Accounts Receivable | -28.17 | -30.72 | -1.11 | 1.51 | -1.93 |
Change in Inventory | -10.62 | -8.74 | 1.32 | -3.14 | -1.45 |
Change in Accounts Payable | 28.69 | 19.62 | 9.36 | -4.66 | 1.41 |
Change in Other Net Operating Assets | -43.65 | 46.25 | -42.34 | 14.25 | 7.58 |
Operating Cash Flow | 22.11 | 78.24 | 9.11 | 41.22 | 6.17 |
Operating Cash Flow Growth | -71.75% | 759.05% | -77.90% | 567.73% | 171.94% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -78.06 | -298.04 | -32.89 | -5.05 | -28.93 |
Investment in Securities | 72.81 | -99.14 | -42.5 | -18.29 | 0.73 |
Other Investing Activities | 0.93 | 1.61 | - | 0.01 | 0.09 |
Investing Cash Flow | -4.32 | -395.57 | -75.39 | -23.33 | -28.11 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | - | - | - | 18.45 |
Long-Term Debt Repaid | - | - | -24.82 | -0.74 | - |
Net Debt Issued (Repaid) | - | - | -24.82 | -0.74 | 18.45 |
Issuance of Common Stock | - | 348.2 | 80.85 | - | 4.9 |
Other Financing Activities | 0.49 | 2.8 | -0.01 | -0.08 | -0.15 |
Financing Cash Flow | 0.49 | 351.01 | 56.02 | -0.82 | 23.2 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - |
Net Cash Flow | 18.27 | 33.68 | -10.26 | 17.08 | 1.27 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -55.96 | -219.79 | -23.78 | 36.17 | -22.75 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -6.31% | -47.75% | -8.73% | 21.16% | -66.44% |
Free Cash Flow Per Share | -3.39 | -14.38 | -2.01 | 3.62 | -6.40 |
Levered Free Cash Flow | -62.63 | -213.46 | 11.48 | 34.47 | -20.6 |
Unlevered Free Cash Flow | -61.65 | -213.38 | 11.5 | 34.52 | -20.51 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | - | - | 0.01 | 0.08 | 0.15 |
Cash Income Tax Paid | 17.67 | 12.45 | 22.95 | 0.43 | 0.69 |
Change in Working Capital | -53.75 | 29.43 | -32.77 | 7.96 | 5.61 |